Stay updated on Long-term Safety of Dupilumab in Pediatric AD Clinical Trial

Sign up to get notified when there's something new on the Long-term Safety of Dupilumab in Pediatric AD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Long-term Safety of Dupilumab in Pediatric AD Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A temporary NIH announcement about the transition from “Artificial Intelligence” to “Super Intelligence” terminology was removed from the page.
    Difference
    1%
    Check dated 2026-11-09T12:56:12.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-11-02T12:33:05.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    A site-wide notice appears above the ClinicalTrials.gov error page, announcing NIH website updates and a terminology transition from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-26T12:13:02.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov study page continues to display a 403 Forbidden error. The footer revision changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-19T12:56:24.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1, while the page continues to show a 403 error.
    Difference
    0.2%
    Check dated 2026-10-12T14:17:48.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    A 403 Forbidden error page is now displayed, replacing the study content with an access-denied message. The header and footer suggest a site-wide access restriction rather than study information.
    Difference
    19%
    Check dated 2026-09-21T20:19:15.000Z thumbnail image

Stay in the know with updates to Long-term Safety of Dupilumab in Pediatric AD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Long-term Safety of Dupilumab in Pediatric AD Clinical Trial page.